Mounjaro generated $8.7 billion for Lilly in the first quarter of 2026, outperforming Merck's Keytruda, which posted sales of ...
Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s ...
Elections in Indiana, Ohio and Michigan reinforced a picture about both Democrats and Republican's positions coming into the ...
Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results